Abstract
A patient with acquired agammaglobulinemia was treated with plasmapheresis. The rationale for this procedure was based on the presence of a cytotoxic autoantibody with specificity for helper (TH2-) T lymphocytes. Plasmapheresis reduced the autoantibody concentration to undetectable levels, which resulted in an increased number of helper T cells. These T cells provided normal in vitro helper activity. Plasmapheresis did not correct a concomitant suppressor T-cell defect, and the clinical remission ended during the fifth month of exchange therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 233-235 |
Number of pages | 3 |
Journal | Blood |
Volume | 59 |
Issue number | 2 |
DOIs | |
State | Published - 1982 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology